FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28922811000001101: Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
90790501000001110 Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
90790601000001114 Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Is a Co-fluampicil 250mg/250mg capsules false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Is a Co-fluampicil 250mg/250mg capsules true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Is a Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has active ingredient Ampicillin false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has specific active ingredient Ampicillin trihydrate true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has specific active ingredient Flucloxacillin sodium true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Has basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) 28 capsule Has AMP True Co-fluampicil 250mg/250mg capsules (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start